Global Health Limited 2022 Annual Report Released

Global-Health-2022 annual report investor-presentation

Global Health Limited 2022 Annual Report Released

Global Health Limited is pleased to present our full year-2022 annual report and business update.

Financial highlights

A year of investment, following a capital raising, has delivered a material increase in sales, marketing and software development capability. Reduced professional service revenue in FY22 impacted the top line, however, recently secured sales will remediate this in FY23.

  • Available Cash and Cash Equivalents $6,376,082 (+32%)
  • Annual Recurring Revenue $5,186,222 (+10%)
  • Total Expenses $8,546,161 (+6%)
  • Total Revenue and Income $6,536,631 (+13%)
  • EBIT ($1,976,059)
  • EBITDA * ($1,688,268)
  • Net Total Operating Cash Flow ($1,182,580) (+186%)

(Unaudited Non IFRS Financial Information)*

Key statistics

  • Recurring Revenue Recurring revenue base of the business increased 10% to $5.19m.
  • One Off Customer Revenue Professional services down 58% onboarding/covid restrictions. We will see a significant uplift in one-off revenue in FY23 as a result of sales created in FY22.
  • New Contract Value Recurring revenue uplift from new contracts was secured late H2 FY22. H1 FY23 CARR will exceed the FY22 full year results. Contracted Annual Recurring Revenue (CARR) $800k secured since April 2022.

Profit and loss

Key comments

  • Annual recurring revenue at record high $5,186,222
  • Other customer revenue down 41%
  • Expected increase in FY23 topline due to recent sales
  • Total comprehensive loss up 320%
    • Increased marketing and staff investment
    • Decreased professional services revenue
  • Staff costs up 33%
    • Consistent with strategy of investment in sales team and key management personnel
    • Market wage pressure for key roles has impacted the cost base
  • Marketing costs up 39%
    • Increased investment in sales and marketing

Key Updates

Sales and marketing update

Sales and marketing activity

  • Additional new sales BDM
  • More events + target brand campaigns
  • Focus on conversion
  • Cross sell/ Always on campaigns optimise
  • Nurture campaigns to warm prospects

Implementations

  • Waratah, WAMHC, Ballarat and Peninsula Health

New Contract Wins

  • Homeless Healthcare (WA), Peninsula Health (Vic), Arcadia Pittwater Hospital (NSW), Matilda Nepean Private Hospital (NSW), Waikiki Private Hospital (WA)
  • Yarram District Health Service (Vic) (July 22), Latrobe Community Health (Vic) (August 22

Customer success and product focus

Listening to customers

  • Pilots are underway to test solutions in collaboration with clients
  • User group meetings to act as ‘sounding board’ for additional development

New product innovation

  • Connect mobile application for in home care
  • Patient Portal integration for greater patient engagement

Enhanced capability

  • Account management model successfully rolled out
  • Consultative engagement model delivered for account management
  • Structured support model developed for quicker client resolution

New product innovation

Inpatient Electronic Medical Record (iEMR)

Identified a gap for private/independent hospitals to digitise their patient records, this integrates with existing Patient Administration systems (PAS). The solution is being co-designed with clients and delivery of modules starts late 2022.

Inpatient EMR offers:

  • A roadmap to complete digitisation
  • Supports HL7, FHIR and interoperability
  • Feature rich, web-based patient management ~ monitor in-patient stays

Many of our clients have already expressed interest in this new solution.

Overseas Market Development

  • Appointment of Martin Murnaghan as a Non-Executive Director to drive overseas market development
  • Appointment of Regional CEO Robin Armstrong to drive and develop ASEAN opportunities
  • Focus on expanding B2B partnerships and client growth as well as facilitate Global Health’s expansion into these key strategic markets
  • Drive subscription revenue from the Global Health community portfolio of patient-centric SaaS platforms which provide a rich set of digital engagement tools and secure connectivity for clinicians and consumers

Moving Forward

Our growth

Strong balance sheet and a positive pipeline of opportunity.

  • Deals were slow to sign in FY21-22 ~ federal election and budget constraints. Decision-making timings returning to normal.
  • In home care capabilities position us well to capitalise on this rapidly emerging demand in healthcare.
  • More sales resource; integrated cross-sell activity, and an uplift in brand activities to drive top of funnel.
  • Delivered a new MasterCare website to improve conversion.

Outcome of recent contract wins Master-Care.com.au

  • Contracted Annual Recurring Revenue (CARR) lifted over $800k since April 2022
  • Contracted Professional services revenue lifted over $1,300,000 since 1 April 2022.

To view the full update please click here.